FDA Approves New Targeted Drug for Advanced Pancreatic Cancer
The U.S. Food and Drug Administration (FDA) approved daraxonrasib, marketed as Rasonque by Revolution Medicines, on Wednesday. The daily oral pill targets multiple forms of a protein called RAS to ... Read More